Small scale production of novel therapeutic products–––a new challenge for the transfusion service?
- 1 March 1993
- journal article
- Published by Wiley in Transfusion Medicine
- Vol. 3 (1) , 1-5
- https://doi.org/10.1111/j.1365-3148.1993.tb00098.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Products in the U.S. PipelineBio/Technology, 1991
- Man-made antibodiesNature, 1991
- Structure of the T cell antigen receptor (TCR): two CD3 epsilon subunits in a functional TCR/CD3 complex.The Journal of Experimental Medicine, 1991
- Clearance of Rh D-positive red cells with monoclonal anti-DThe Lancet, 1990
- Monoclonal-Antibody Therapy in Systemic VasculitisNew England Journal of Medicine, 1990
- REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1HThe Lancet, 1988
- T CELL DEPLETION WITH CAMPATH-1 IN ALLOGENEIC BONE MARROW TRANSPLANTATIONTransplantation, 1988
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Therapeutic Strategies for B Cell Malignancies Involving Idiotype-Anti-idiotype InteractionsInternational Reviews of Immunology, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985